Onderneming Neovasc Inc.
Aandelen
NVCN
CA64065J4037
Geavanceerde medische apparatuur & technologie
Vakgebied
Aantal werknemers: 60
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sarah Gallagher
CTO | Chief Tech/Sci/R&D Officer | - | 13-07-21 |
Shmuel Banai
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alexei J. Marko
BRD | Director/Board Member | 56 | 12-06-03 |
Investor Relations Contact | 54 | 02-04-07 | |
Lisa Becker
LAW | General Counsel | - | 13-07-21 |
John Panton
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Geyer
BRD | Director/Board Member | 61 | 02-11-00 |
Alexei J. Marko
BRD | Director/Board Member | 56 | 12-06-03 |
Douglas Janzen
BRD | Director/Board Member | 56 | 02-06-05 |
Norman J. Radow
BRD | Director/Board Member | - | 16-09-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 783 553 | 2 556 708 ( 91,85 %) | 0 | 91,85 % |
Bedrijfsgegevens
![Adres Neovasc Inc.(NVCN)](https://cdn.zonebourse.com/static/address/61175372.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,00% | 185 mld. | |
+31,86% | 158 mld. | |
+33,21% | 113 mld. | |
+2,28% | 64,32 mld. | |
+21,14% | 55,66 mld. | |
+0,11% | 48,41 mld. | |
-6,76% | 37,82 mld. | |
+0,78% | 35,57 mld. | |
+11,28% | 28,12 mld. |